April 22, 2024 Comments Off on New patent expiration for Galderma Labs drug SOOLANTRA Posted in: Uncategorized
Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are twelve…
Source
April 22, 2024 Comments Off on New tentative approval for Xiamen Lp drug topiramate Posted in: Tentative Approval [](//www.DrugPatentWatch.com/p/preview/generic-api/topiramate?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Topiramate is the generic in…
